Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes (Q36841961)

16 August 2017

Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes (English)

1 reference

16 August 2017

1 reference

1

Julio Rosenstock

1 reference

16 August 2017

2

William T Cefalu

1 reference

16 August 2017

Priscilla A Hollander

3

1 reference

16 August 2017

Andre Belanger

4

1 reference

16 August 2017

Freddy G Eliaschewitz

5

1 reference

16 August 2017

Jorge L Gross

6

1 reference

16 August 2017

Solomon S Klioze

7

1 reference

16 August 2017

Lisa B St Aubin

8

1 reference

16 August 2017

Howard Foyt

9

1 reference

16 August 2017

Masayo Ogawa

10

1 reference

16 August 2017

William T Duggan

11

1 reference

16 August 2017

language of work or name

English

0 references

publication date

5 June 2008

1 reference

16 August 2017

1 reference

16 August 2017

31

1 reference

16 August 2017

9

1 reference

16 August 2017

1723-1728

1 reference

Standardization of the single-breath diffusing capacity in a multicenter clinical trial.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Lung function changes related to diabetes mellitus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Decline in lung function and mortality: the Busselton Health Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Spirometric reference values from a sample of the general U.S. population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Standardization of Spirometry, 1994 Update. American Thoracic Society

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Lung volumes in healthy nonsmoking adults.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

The natural history of chronic airflow obstruction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

Meaningful effect size and patterns of response of the transition dyspnea index

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2518332

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

5 September 2018

1 reference

12 December 2020

Nodular fibrosis of the lung in diabetes mellitus

1 reference

12 December 2020

American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update

1 reference

12 December 2020

Diabetes mellitus induces a thickening of the pulmonary basal lamina

1 reference

12 December 2020

Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial

1 reference

12 December 2020

Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy

1 reference

12 December 2020

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

1 reference

12 December 2020

Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design

1 reference

12 December 2020

Instrument accuracy and reproducibility in measurements of pulmonary function

1 reference

12 December 2020

Finding signals amidst the noise in pulmonary function testing

1 reference

12 December 2020

Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC08-0159

1 reference

release_fxwgkisgo5e5hizbjl3snm5bz4

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fxwgkisgo5e5hizbjl3snm5bz4

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

1 reference